admin

Adam Jeffery | CNBC After experiencing unusually broad market momentum since November, stocks are overdue for a lengthy pause or a correction. Stock picking will matter from here as the economic reopening determines different winners and losers. According to a team of J.P. Morgan strategists, “it wouldn’t be surprising to witness consolidation” given the current
0 Comments
Hedge funds employ some of the best-paid business professionals anywhere, but landing your first job in the industry is no cakewalk. Building a hedge fund career takes determination, networking stamina, and a fierce competitive streak. Here are some steps to help get you to that interview and then land that job. Whether you are looking for
0 Comments
We discuss why bitcoin has been soaring and whether we will see a bitcoin ETF soon. iShares Gold Trust: https://www.zacks.com/funds/etf/IAU/profile?cid=CS-YOUTUBE-FT-VID SPDR Gold Shares: https://www.zacks.com/funds/etf/GLD/profile?cid=CS-YOUTUBE-FT-VID Ark Innovation ETF: https://www.zacks.com/funds/etf/ARKK/profile?cid=CS-YOUTUBE-FT-VID Ark Web ETF: https://www.zacks.com/funds/etf/ARKW/profile?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments
Overall, “5G” could be one of hottest buzzwords of the year. And that, in turn, makes 5G stocks a major topic of discussion. After all, according to Cowen & Co. analyst Colby Synesael, it will “usher in this revolution and have a ‘game-changing’ impact on society. Certainly, there are already several technologies including artificial intelligence,
0 Comments
Check out the companies making headlines before the bell: Walmart (WMT) – Walmart reported adjusted quarterly earnings of $1.39 per share, which includes a 7-cent impact from UK tax repayment. The consensus estimate had been $1.50. Revenue did beat forecasts, and US comparable sales excluding fuel were up 8.6% compared to the 5.8% FactSet estimate.
0 Comments
Carl Icahn at the 6th annual CNBC Institutional Investor Delivering Alpha Conference on September 13, 2016. Heidi Gutman | CNBC Company: Bausch Health Companies Inc. (BHC) Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter
0 Comments